Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
HUMIRA (adalimumab) is a recombinant human IgG1 monoclonal antibody specific for human tumor necrosis factor (TNF). HUMIRA was created using phage display technology resulting in an antibody with human derived heavy and light chain variable regions and human IgG1:k constant regions. Adalimumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) expression system and is purified by a process that includes specific viral inactivation and removal steps. It consists of 1330 amino acids and has a molecular weight of approximately 148 kilodaltons.
Adalimumab is supplied at a concentration of 50 mg/mL as a sterile, clear and colorless, preservative-free solution, which contains 1.3 mg/mL citric acid monohydrate, 1.525 mg/mL dibasic sodium phosphate dihydrate, 12 mg/mL mannitol, 0.8625 mg/mL monobasic sodium phosphate dihydrate, 1 mg/mL polysorbate 80, 6.1625 mg/mL sodium chloride, 0.3 mg/mL sodium citrate and Water for Injection.
Properties
Name | Adalimumab |
CAS NO. | 331731-18-1 |
Type | Whole antibody |
Source | Human |
Target | TNF alpha |
Clone | Monoclone |
Formula | C6428H9912N1694O1987S46 |
Molecular Weight | 148 kDa |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China(Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Adalimumab
